Celldex Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2008 | — | — | $44.3M |
| FY2009 | — | — | $57.0M |
| FY2010 | $34.7M | $109.9M | $21.3M |
| FY2011 | $29.3M | $98.0M | $11.9M |
| FY2012 | $29.8M | $125.5M | $24.9M |
| FY2013 | $27.3M | $347.1M | $169.4M |
| FY2014 | $36.4M | $248.0M | $28.0M |
| FY2015 | $47.5M | $337.6M | $72.1M |
| FY2016 | $117.9M | $383.4M | $42.5M |
| FY2017 | $79.3M | $315.6M | $40.3M |
| FY2018 | $31.7M | $155.8M | $24.3M |
| FY2019 | $28.9M | $122.9M | $11.2M |
| FY2020 | $26.5M | $235.8M | $43.8M |
| FY2021 | $25.2M | $444.7M | $39.1M |
| FY2022 | $26.5M | $352.7M | $29.4M |
| FY2023 | $36.5M | $465.6M | $34.8M |
| FY2024 | $45.3M | $792.3M | $28.4M |
| FY2025 | $55.8M | $583.0M | $28.9M |